Figure 5 showed that KIF2C expression was significantly positively correlated with immune and stromal scores in KIRC, LGG, and THCA, but negatively correlated with those in GBM, LUSC, STAD, and UCEC. In addition, high KIF2C expression was negatively correlated with stromal scores in BRCA, COAD, HNSC, LIHC, LUAD, SARC, SKCM, TGCT, and THYM, and negatively correlated with immune scores in DLBC (Supplementary Figure S3). This evidence concerns the gene KIF2C and glioblastoma.